February 6, 2025
Secondary CVD Medications Remain Underused Globally
A recent PURE study has found that secondary prevention medications for cardiovascular diseases (CVD), which help prevent further health complications,...
Read MoreFebruary 6, 2025
A recent PURE study has found that secondary prevention medications for cardiovascular diseases (CVD), which help prevent further health complications,...
Read MoreFebruary 3, 2025
An analysis of the ARTESiA study found that the blood thinner apixaban helps prevent stroke in people with device-detected subclinical...
Read MoreJanuary 23, 2025
PHRI Scientist Jason Roberts has been named as the inaugural Marianne Barrie/PHRI Chair in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Research,...
Read MoreDecember 19, 2024
Driven by its commitment to operational excellence and advancing clinical research, PHRI is proud to be among the first to...
Read MoreDecember 16, 2024
At the CVCT 2024 Global Forum, PHRI researchers delivered a range of presentations on cardiovascular research design and inclusivity, and the...
Read MoreDecember 13, 2024
Monitoring clinical trials that evaluate the effectiveness and safety of a treatment or intervention is key to ensuring data accuracy,...
Read MoreBack To Top